Skip to main content
Toggle navigation
Login
Search
Home
Back
Favorite
0
Like
Facebook
Tweet
Print
Session XI: ALL
Debate: Best Therapy for Acute Lymphocytic Leukemia in First Relapse or Disease Refractory to Standard Treatment: CAR-T Cell Therapy
Saturday, April 23, 2022
3:50 PM – 4:05 PM
Debate Speaker(s)
Jae Park, MD
Associate Attending Physician
Memorial Sloan Kettering Cancer Center
New York, New York
Learning Objectives:
Identify the molecular targets for currently available treatments for R/R ALL
Summarize key efficacy and safety data for approved therapeutic regimens for R/R ALL